San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Trovagene, Viking Therapeutics Report Q1 Earnings

Two San Diego life science companies reported earnings Tuesday afternoon, one missing Wall Street expectations and the other beating predictions.

DJO Reports $278.9 Million in Net Sales for Q1

DJO Global Inc., a medical device company based in Vista, announced its first quarter results, ending April 1.

Tease photo

Amit D. Munshi Chosen to Lead Arena Pharmaceuticals

Ending a months-long search for a new chief executive, San Diego’s Arena Pharmaceuticals Inc. announced Tuesday that it has appointed Amit D. Munshi as president, CEO, and interim principal financial officer.

Otonomy Inc. Reports Q1 Earnings, Gives Corporate Update

San Diego drugmaker Otonomy Inc. reported financial earnings and a corporate update Monday.

Apricus Biosciences Releases First Quarter Results

San Diego-based biopharmaceutical company Apricus Biosciences Inc. reported total revenue of $626,000 for the first quarter of 2016, with a net loss of $2.5 million.

Shares of Sophiris Bio Inc. Slip

Shares of Sophiris Bio Inc. are down over 18 percent Monday after the La Jolla firm announced plans to sell shares in the company at $1.40 per share to raise about $5 million.

Sorrento Therapeutics Hires Advisors to Evaluate 'Potential Alternatives'

San Diego’s biopharmaceutical firm Sorrento Therapeutics Inc. has hired advisors to help the company come up with strategies to boost shareholder value, the company said in a news release. The announcement comes shortly after a minority shareholder publicly expressed dissatisfaction with the company’s management.

Biosortia Pharmaceuticals Inc. Launches 3 Oncology Research Projects

Biosortia Pharmaceuticals Inc., a biopharma company that recently moved to San Diego from Ohio, has launched three new oncology research projects.

Drugmakers Mirati, Neurocrine Report Q1 Earnings

Two San Diego drugmakers reported financial earnings Thursday.

Tease photo

Linda Vista Health Center Expands to Meet Community Needs

A nonprofit community clinic has more than doubled its footprint in Linda Vista following a surge of newly-insured patients. Linda Vista Health Center, part of a seven-clinic umbrella corporation called San Diego Family Care, has added 23,000 square feet to its existing space in a $2.7 million expansion to accommodate the need.

Tease photo

Birth of a Blockbuster?

PHARMA: Acadia Prepares To Launch Drug to Treat Parkinson’s Psychosis

Acadia Pharmaceuticals Inc. has earned the greenlight from regulators to sell a valuable antipsychotic drug. The medication, potentially worth billions, quells the hallucinations and delusions experienced by Parkinson’s disease patients. And it’s the first of its kind.

Stocks Down For 3 Life Science Firms After Earnings Reports

Three public life science firms in San Diego are suffering stock slips after reporting first quarter earnings Wednesday. Two of the firms missed analyst expectations and one exceeded Wall Street’s forecast, but barely.

Ionis Sells Drug Rights to Kynamro in Deal Potentially Worth More Than $95M

In a deal worth up to $95 million-plus, San Diego drugmaker Ionis Pharmaceuticals sold global rights to develop and commercialize its marketed drug Kynamro to Chicago-based Kastle Therapeutics.

Illumina's Revenue Fails to Match Forecasts for Q1

San Diego’s Illumina Inc. reported quarterly earnings May 3, falling short of analyst expectations and further slipping the company’s stock.

Dexcom Inc. Acquires European Distribution Partner Nintamed

Dexcom Inc., one of San Diego’s biggest public medical technology firms, announced May 2 that it will acquire Nintamed, a distribution partner with presence in Germany, Switzerland and Austria.